# Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis

> **NCT05651880** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 33 (estimated)

## Conditions studied

- Active Non-anterior Non-infectious Uveitis

## Interventions

- **DRUG:** Baricitinib 4 MG

## Key facts

- **NCT ID:** NCT05651880
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2029-08
- **Final completion:** 2029-08
- **Target enrollment:** 33 (ESTIMATED)
- **Last updated:** 2026-02-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05651880

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05651880, "Efficacy and Tolerance of Baricitinib, a JAK Inhibitor, in the Treatment of Refractory Non-infectious Non-anterior Uveitis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05651880. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*